Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration

Metastatic melanoma is an aggressive cancer with a poor prognostic, and the design of new targeted drugs to treat melanoma is a therapeutic challenge. A promising approach is to produce monoclonal antibodies (mAbs) against the endothelin B receptor (ETB), which is known to be overexpressed in melano...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Borrull, Aurélie, Allard, Bertrand, Wijkhuisen, Anne, Herbet, Amaury, Lamourette, Patricia, Birouk, Wided, Leiber, Denis, Tanfin, Zahra, Ducancel, Frédéric, Boquet, Didier, Couraud, Jean-Yves, Robin, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058623/
https://ncbi.nlm.nih.gov/pubmed/27390909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1208865
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados